Evidence map›Paper›PMID 42682968›Full record

ReviewFrontiers in pain research (Lausanne, Switzerland)2026

Electromagnetic neuromodulation for chronic pain: historical context, contemporary modalities, and evidence gaps.

Laura Dipietro, Ciro Ramos-Estebanez, Paola Gonzalez-Mego, Anna Carolyna Gianlorenco, Arisara Wongtanawat, Christopher Robinson, Salim M Hayek, Felipe Fregni, Timothy Wagner

Abstract readReview
In one paragraph

Review in Frontiers in pain research (Lausanne, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Laura DipietroHighland Instruments, Cambridge, MA, United States.
Ciro Ramos-EstebanezDepartments of Neurology and Rehabilitation, and Neurosurgery, University of Illinois at Chicago, Chicago, IL, United States.
Paola Gonzalez-MegoSpaulding Neuromodulation Center, Spaulding Rehabilitation Hospital and Massachusetts General Hospital, Boston, MA, United States.
Anna Carolyna GianlorencoSpaulding Neuromodulation Center, Spaulding Rehabilitation Hospital and Massachusetts General Hospital, Boston, MA, United States.
Arisara WongtanawatDepartments of Neurology and Rehabilitation, and Neurosurgery, University of Illinois at Chicago, Chicago, IL, United States.
Christopher RobinsonDivision of Pain, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Salim M HayekDivision of Pain Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.
Felipe FregniSpaulding Neuromodulation Center, Spaulding Rehabilitation Hospital and Massachusetts General Hospital, Boston, MA, United States.
Timothy WagnerHighland Instruments, Cambridge, MA, United States.

Funding

CRP: Noninvasive brain stimulation for chronic pain treatmentSB1AG091887 · NIA · HIGHLAND INSTRUMENTS, INC. · PI Laura Dipietro, Timothy Andrew Wagner · 2025 to 2026
$4.0M
ESStim for the Treatment of Postural Instability in Patients with Parkinson's Disease - Phase IIBR44NS110237 · NINDS · HIGHLAND INSTRUMENTS, INC. · PI Laura Dipietro, Timothy Andrew Wagner · 2019 to 2026
$3.2M
Noninvasive Brain Stimulation for Treating Addiction (Supplement)R44DA049685 · NIDA · HIGHLAND INSTRUMENTS, INC. · PI DIPIETRO, LAURA, WAGNER, TIMOTHY ANDREW · 2019 to 2024
$3.0M
Optimizing Technology and Treatment for Non Specific Chronic Low Back PainR44AG055360 · NIA · HIGHLAND INSTRUMENTS, INC. · PI DIPIETRO, LAURA, WAGNER, TIMOTHY ANDREW · 2016 to 2020
$1.7M
Enhancing Physical Therapy: Noninvasive Brain Stimulation System for Treating Carpal Tunnel SyndromeR44AR076885 · NIAMS · HIGHLAND INSTRUMENTS, INC. · PI DIPIETRO, LAURA, WAGNER, TIMOTHY ANDREW · 2019 to 2023
$1.7M
Commercial Readiness in CTS Pain ManagementSB1AR083748 · NIAMS · HIGHLAND INSTRUMENTS, INC. · PI DIPIETRO, LAURA, WAGNER, TIMOTHY ANDREW · 2023 to 2023
$400k
Biomarkers for Opioid Use Disorder (OUD)R43DA058979 · NIDA · HIGHLAND INSTRUMENTS, INC. · PI DIPIETRO, LAURA, WAGNER, TIMOTHY ANDREW · 2023 to 2023
$320k
NIAMS NIH HHS R44 AR076885NIAMS NIH HHS SB1 AR083748NIA NIH HHS R44 AG055360NIA NIH HHS SB1 AG091887NIDA NIH HHS R43 DA058979NIDA NIH HHS R44 DA049685NINDS NIH HHS R44 NS110237
6 · The paper itself

Abstract

Electromagnetic neuromodulation is increasingly used as an adjunct or alternative to pharmacologic therapy for pain, with several approaches cleared for select indications and many others under active investigation. We review implanted neuromodulation approaches (intracranial and spinal), vagal neuromodulation, noninvasive central/cranial neuromodulation, peripheral neuromodulation, and hybrid/multimodal approaches, with a primary focus on chronic pain management and brief coverage of selected acute-use indications (e.g., primary headache disorders) where relevant. Beyond summarizing individual modalities, we highlight the recurring patterns that have shaped the evolution of pain neuromodulation. For each modality, we summarize putative mechanism of action, typical stimulation paradigms, and key strengths and limitations of the clinical evidence, emphasizing sources of heterogeneity that complicate cross-study comparison and translation. We conclude by outlining priorities for the field, including more rigorous trial design, standardized reporting of stimulation parameters and outcomes, and clearer indication-specific evidence to support clinical translation.

Indexed as

brain stimulationcentral sensitizationchronic painneuromodulationperipheral nerve stimulationspinal cord stimulationtranscranial direct current stimulationtranscranial magnetic stimulation

Identifiers

PMID42682968
PMCPMC13531069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.